Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Exploratory Research in Clinical and Social Pharmacy is Scopus-indexed (Q1, CiteScore 3.6), WoS ESCI, DOAJ. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 2667-2766Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacy | 8 / 52 | 85th | Q1 |
| Pharmacology (medical) | 147 / 278 | 47th | Q3 |
| Health, Toxicology and Mutagenesis | 94 / 151 | 38th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 3.6.
Exploratory Research in Clinical and Social Pharmacy is Q1 in Pharmacy (rank 8 of 52), Q3 in Pharmacology (medical) (rank 147 of 278) and Q3 in Health, Toxicology and Mutagenesis (rank 94 of 151), by CiteScore 2025.
Exploratory Research in Clinical and Social Pharmacy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.649, quartile Q1, with an H-index of 18.
The publisher lists an article processing charge of about US$2,140 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Exploratory Research in Clinical and Social Pharmacy is published by Elsevier Inc. Its ISSN is 2667-2766.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Exploratory Research in Clinical and Social Pharmacy has an h-index of 24 and a 2-year mean of 2.58 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q1. On 2-year citations it ranks #5 of 50 Scopus journals in Pharmacy.
Exploratory Research in Clinical and Social Pharmacy published 142 papers in 2025; its busiest recent year was 2023 with 184. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from United States (9.4%), Ireland (6.4%) and Ethiopia (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.